TREXICEF-OF

				
					Composition: Cefixime (200mg) + Ofloxacin (200mg)

An advanced antibiotic combination. Cefixime (3rd gen Cephalosporin) inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Ofloxacin (Fluoroquinolone) targets the bacterial DNA Gyrase and Topoisomerase IV enzymes, preventing the DNA from uncoiling and replicating. This dual-class approach provides "bactericidal synergy," killing bacteria at two different life stages.

Broad Spectrum: Covers a wide array of aerobic and anaerobic, Gram-positive, and Gram-negative pathogens. Resistance Prevention: The combination makes it much harder for bacteria to develop "evasive mutations" compared to single-drug therapy. Tissue Penetration: Ofloxacin has excellent penetration into the lungs, skin, and urinary tract.

Generally Prescribed for Following:

Systemic Infections: Enteric fever (Typhoid) that is resistant to first-line drugs.
Respiratory: Severe bronchitis and community-acquired pneumonia.
Urogenital: Complicated Urinary Tract Infections (UTIs) and Pelvic Inflammatory Disease (PID).
Skin: Deep-seated skin and soft tissue infections.

Potential Side Effects and Adverse Reactions:

Gastrointestinal: Nausea, vomiting, and "Antibiotic-Associated Diarrhea." Musculoskeletal: Ofloxacin carries a risk of tendonitis or tendon rupture (especially the Achilles tendon). CNS: Rare instances of dizziness, insomnia, or "brain fog." Hypersensitivity: Skin rashes or urticaria.

General Advisories and Critical Avoidances:

Alcohol: AVOID. May cause a "disulfiram-like reaction" (severe vomiting/palpitations).
Food: Do not take with dairy products (calcium) or antacids, as they bind to Ofloxacin and prevent absorption.
Lactation: Generally avoided; consult a doctor.
Sunlight: Causes photosensitivity; avoid direct sun exposure.

GET IN TOUCH

Need Any Help

Direct Contact with us